Edition:
United Kingdom

Guerbet SA (GRBT.PA)

GRBT.PA on Paris Stock Exchange

50.90EUR
23 Aug 2019
Change (% chg)

-- (--)
Prev Close
€50.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,294
52-wk High
€65.50
52-wk Low
€46.00

About

Guerbet SA is a France-based pharmaceutical group specialized in the manufacture and marketing of medical imaging contrast agents destined for diagnostic purposes. It produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents... (more)

Overall

Beta: 0.53
Market Cap(Mil.): €1,061.47
Shares Outstanding(Mil.): 12.50
Dividend: 0.85
Yield (%): 1.00

Financials

  GRBT.PA Industry Sector
P/E (TTM): 37.00 29.89 32.67
EPS (TTM): 2.29 -- --
ROI: 4.32 14.89 14.48
ROE: 9.69 16.01 15.78

BRIEF-Guerbet: Transition From Temporary Importation To Regular Supply For Lipiodol Injection

* GUERBET LLC USA ANNOUNCED ON MONDAY TRANSITION FROM TEMPORARY IMPORTATION TO REGULAR SUPPLY FOR LIPIODOL (ETHIODIZED OIL) INJECTION; ALSO INTRODUCES NEW GLASS VIAL CONTAINER

02 Apr 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates